C209 (Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg)
Pill with imprint C209 is Blue, Capsule-shape and has been identified as Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg / 300 mg. It is supplied by Exelan Pharmaceuticals, Inc..
Emtricitabine/tenofovir is used in the treatment of pre-exposure prophylaxis; hiv infection; occupational exposure; nonoccupational exposure and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Emtricitabine/tenofovir 200 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for C209
Emtricitabine and Tenofovir Disoproxil Fumarate
- Imprint
- C209
- Strength
- 200 mg / 300 mg
- Color
- Blue
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Exelan Pharmaceuticals, Inc.
- Manufacturer
- Appco Pharma LLC
- National Drug Code (NDC)
- 76282-0677
Related Images for "C209"
More about emtricitabine / tenofovir
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 32 Reviews
- Drug class: antiviral combinations
Consumer resources
- Patient Information
- Emtricitabine and tenofovir (Advanced Reading)
- Emtricitabine and Tenofovir Disoproxil Fumarate
- Other brands
- Truvada, AccessPak for HIV PEP Basic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.